Release Date: 09/10/14 10:32 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 196.73KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%